Internal Medicine, Endocrinology, Diabetes, & Metabolism · Westfield, NJ
NPI
1427437847
Since 2015
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
525 Central Ave Ste D
Westfield, NJ, 07090
Phone (908) 389-1910
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
1,069 services
Medicare patients, 2024
269
Average age 72
Drug cost, 2024
$1.8M
3,998 prescriptions
Company payments, 2025
$1,136
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zulekha Atif was code 99214 (office e&m - established), 323 times for 173 patients. In total Zulekha Atif billed 1,069 services in 14 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 323 | 173 | $96.16 | $31K |
| 95251 Test - Miscellaneous | Office | 82 | 38 | $27.55 | $2,259 |
| 99204 Office E&M - New | Office | 56 | 56 | $132.85 | $7,440 |
| 99213 Office E&M - Established | Office | 52 | 42 | $62.61 | $3,256 |
| 99203 Office E&M - New | Office | 20 | 20 | $91.86 | $1,837 |
By year: 2022 $43K for 784 services; 2023 $48K for 1,089 services; 2024 $47K for 1,069 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 19 | $2.98 | $56.7 |
Medicare prescription drug claims, 2024
In 2024, the drug Zulekha Atif prescribed most often to Medicare patients was Ozempic (Semaglutide), with 299 prescriptions and refills. In total Zulekha Atif wrote 3,998 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 299 | 484 | 64 | $452K |
| Levothyroxine Sodium Generic | 290 | 707 | 83 | $3,426 |
| Metformin Hcl Generic | 281 | 728 | 93 | $2,993 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 212 | 463 | 70 | $27K |
| Jardiance Empagliflozin | 190 | 365 | 52 | $206K |
| Rosuvastatin Calcium Generic | 125 | 309 | 43 | $1,751 |
| Atorvastatin Calcium Generic | 124 | 307 | 52 | $1,349 |
| Mounjaro Tirzepatide | 122 | 162 | 26 | $168K |
| Trulicity Dulaglutide | 122 | 196 | 31 | $190K |
| Metformin Hcl Er Metformin Hcl | 121 | 300 | 40 | $1,367 |
| Humalog Kwikpen U-100 Insulin Lispro | 108 | 229 | 37 | $36K |
| Farxiga Dapagliflozin Propanediol | 103 | 179 | 28 | $99K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 97 | 202 | 41 | $8,570 |
| Januvia Sitagliptin Phosphate | 93 | 193 | 25 | $104K |
| Repaglinide Generic | 81 | 210 | 27 | $2,177 |
Brand drugs: 1,972 claims; generic drugs: 1,673 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zulekha Atif $1,136 ($1,136 in general payments such as food, travel and fees) from 21 companies. The largest payer was KVK-Tech, Inc. with $197.
| Company | Payments | Amount |
|---|---|---|
| KVK-Tech, Inc. | 1 | $197 |
| Novo Nordisk Inc NVO | 11 | $193 |
| Radius Health, Inc. | 2 | $104 |
| Madrigal Pharmaceuticals MDGL | 3 | $75.97 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $73.97 |
| Alvogen Inc | 3 | $64.8 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51.83 |
| Medtronic, Inc. MDT | 2 | $49.01 |
| Insulet Corporation PODD | 2 | $46.75 |
| Lilly USA, LLC LLY | 3 | $45.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.